Gepride M 2 Forte Tablet Sr
₹151
₹151
Gepride
Gepride M 2 Forte Tablet Sr
Net Qty: 10 Tablets
MRP₹151(incl. of all taxes)
Prescription required
Coupons & Offers
No Return or Exchange
Fast Delivery
Highlights
composition with strength
Glimepiride(2Mg), Metformin(1000Mg)
dosage form
Tablet
description
Combination of glimepiride and metformin, helps control blood sugar levels, reduces risk of diabetes complications, supports a healthy lifestyle
key benefits
Treatment of Type 2 diabetes mellitus
unit
10 Tablets
side effects
Headache , Nausea , Diarrhea and Flatulence
packaging type
Strip
how to use
Take this medication as prescribed by your doctor. Swallow it whole—do not chew, crush, or break it.
alcohol interaction
Unsafe
pregnancy interaction
Consult Your Doctor
lactation interaction
Unsafe
driving interaction
Caution
kidney interaction
Caution
liver interaction
Caution
Information
customer care details
In case of any issue, contact us E-mail address: support@zeptonow.com
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship. While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
Seller Name
Geddit Convenience Private Limited
Seller Address
Ground Floor, Rahat Manzil Building, Dr Ambedkar Road, Khar West Mumbai, Greater Mumbai, Maharashtra-400052
Seller License No.
11521998000248
Country of Origin
India
Shelf Life
36 months
Expires on or after
September 2025